Insider Trading
Track Major Insider Updates On X/Twitter
ARWR Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on ARWR stock insider trading activity, which can give hints on whether Arrowhead Pharmaceuticals Inc. executives are bullish or bearish on their own company.
Recent insider purchases and sales - ARWR
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 50000 | Apr 10, 2025 | April 11, 2025, 6:20 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 1617 | Apr 09, 2025 | April 11, 2025, 6:20 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 3400 | Apr 09, 2025 | April 11, 2025, 6:20 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 50800 | Apr 11, 2025 | April 11, 2025, 6:20 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 35305 | Apr 09, 2025 | April 11, 2025, 6:20 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 51425 | Mar 13, 2025 | March 17, 2025, 5:45 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 133333 | Mar 04, 2025 | March 5, 2025, 7:32 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 166667 | Mar 03, 2025 | March 5, 2025, 7:32 p.m. |
|
OLUKOTUN ADEOYE Y
|
Sale | 959 | Jan 23, 2025 | Jan. 27, 2025, 8:22 p.m. |
|
Hamilton James C
Chief Discovery/Trans Medicine
|
Sale | 21758 | Jan 06, 2025 | Jan. 7, 2025, 10:28 p.m. |
|
Hamilton James C
Chief Discovery/Trans Medicine
|
Sale | 10971 | Jan 06, 2025 | Jan. 7, 2025, 10:28 p.m. |
|
O'Brien Patrick
COO and General Counsel
|
Sale | 19658 | Jan 06, 2025 | Jan. 7, 2025, 10:28 p.m. |
|
O'Brien Patrick
COO and General Counsel
|
Sale | 8000 | Jan 07, 2025 | Jan. 7, 2025, 10:28 p.m. |
|
O'Brien Patrick
COO and General Counsel
|
Sale | 9526 | Jan 06, 2025 | Jan. 7, 2025, 10:28 p.m. |
|
Myszkowski Kenneth Allen
Chief Financial Officer
|
Sale | 9402 | Jan 06, 2025 | Jan. 7, 2025, 10:27 p.m. |
|
Myszkowski Kenneth Allen
Chief Financial Officer
|
Sale | 10000 | Jan 07, 2025 | Jan. 7, 2025, 10:27 p.m. |
|
Myszkowski Kenneth Allen
Chief Financial Officer
|
Sale | 8000 | Jan 07, 2025 | Jan. 7, 2025, 10:27 p.m. |
|
Myszkowski Kenneth Allen
Chief Financial Officer
|
Sale | 17765 | Jan 06, 2025 | Jan. 7, 2025, 10:27 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 11520 | Jan 02, 2025 | Jan. 6, 2025, 7:07 p.m. |
|
OLUKOTUN ADEOYE Y
|
Sale | 2850 | Dec 27, 2024 | Dec. 30, 2024, 6:12 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 12563 | Dec 23, 2024 | Dec. 23, 2024, 5:39 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 5799 | Dec 18, 2024 | Dec. 20, 2024, 7:04 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 12653 | Dec 18, 2024 | Dec. 20, 2024, 7:04 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 8260 | Dec 18, 2024 | Dec. 20, 2024, 7:04 p.m. |
|
Waddill William D.
|
Sale | 3748 | Dec 16, 2024 | Dec. 18, 2024, 7:19 p.m. |
|
Waddill William D.
|
Sale | 3747 | Dec 17, 2024 | Dec. 18, 2024, 7:19 p.m. |
|
GIVEN DOUGLAS B
|
Sale | 5000 | Dec 16, 2024 | Dec. 18, 2024, 7:18 p.m. |
|
GIVEN DOUGLAS B
|
Sale | 547 | Dec 17, 2024 | Dec. 18, 2024, 7:18 p.m. |
|
Vakiener Victoria
|
Sale | 8994 | Dec 16, 2024 | Dec. 18, 2024, 7:15 p.m. |
|
Oliver Tracie
Chief Commercial Officer
|
Sale | 9394 | Jul 02, 2024 | July 3, 2024, 5:27 p.m. |
|
Vakiener Victoria
|
Sale | 1799 | May 02, 2024 | May 6, 2024, 6:04 p.m. |
|
Hamilton James C
Chief Discovery/Trans Medicine
|
Sale | 6000 | Apr 01, 2024 | April 3, 2024, 6:05 p.m. |
|
Lu Hongbo
|
Purchase | 1000 | Mar 20, 2024 | March 20, 2024, 7:06 p.m. |
|
Lu Hongbo
|
Purchase | 1000 | Mar 18, 2024 | March 20, 2024, 7:06 p.m. |
|
Lu Hongbo
|
Purchase | 1000 | Mar 19, 2024 | March 20, 2024, 7:06 p.m. |
|
Myszkowski Kenneth Allen
Chief Financial Officer
|
Sale | 40000 | Mar 06, 2024 | March 8, 2024, 6:54 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 37769 | Jan 31, 2024 | Feb. 2, 2024, 6:25 p.m. |
|
Anzalone Christopher Richard
Chief Executive Officer
|
Sale | 19730 | Jan 31, 2024 | Feb. 2, 2024, 6:25 p.m. |
|
Hamilton James C
Chief Discovery/Trans Medicine
|
Sale | 3702 | Jan 12, 2024 | Jan. 17, 2024, 7:32 p.m. |
|
Hamilton James C
Chief Discovery/Trans Medicine
|
Sale | 4238 | Jan 12, 2024 | Jan. 17, 2024, 7:32 p.m. |
|
GIVEN DOUGLAS B
|
Sale | 1100 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
GIVEN DOUGLAS B
|
Sale | 1811 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Waddill William D.
|
Sale | 2634 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Waddill William D.
|
Sale | 1300 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Ferrari Mauro
|
Sale | 1000 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Ferrari Mauro
|
Sale | 2147 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Vakiener Victoria
|
Sale | 1100 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Vakiener Victoria
|
Sale | 3620 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
Oliver Tracie
Chief Commercial Officer
|
Sale | 74 | Jan 05, 2024 | Jan. 8, 2024, 6:17 p.m. |
|
Myszkowski Kenneth Allen
Chief Financial Officer
|
Sale | 1400 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |